Data Characteristics in this Category
Data for CRO (Contract Research Organization) clinical trial pre-screening originates from various heterogeneous systems. Sources include clinical trial protocols from sponsors, inclusion/exclusion criteria, medical history, medication records, and laboratory test results. This data typically exists as a mix of unstructured documents (e.g., clinical protocols in PDF, case report forms in Word) and semi-structured data (e.g., laboratory results in CSV or Excel, patient information exported from databases).
Data updates frequently, especially for subject recruitment progress, adverse event reports, and laboratory test results, which may update daily or weekly. Document structures vary, lacking a unified standard template. Field names and unit representations also differ. For example, complete blood count (CBC) units might be g/dL or mmol/L, and drug dosage units might be mg or μg. Normalization is required for these variations.
Constraints Imposed by these Characteristics on Model Integration and Configuration
The data characteristics of CRO clinical trial pre-screening impose specific requirements on model integration and configuration. First, data source heterogeneity necessitates support for multimodal document parsing to handle unstructured text and semi-structured tabular data. Second, high update frequency requires the knowledge base to have an efficient incremental update mechanism, ensuring the model always bases decisions on the latest data.
Diverse document structures mean flexible text segmentation strategies are needed to avoid key information being cut off or redundant. Inconsistent fields and units mandate standardization during data preprocessing. This can involve configuring custom unit conversion rules or regular expression patterns to unify representations for key fields like CBC, biochemical indicators, and drug dosages. Furthermore, due to the sensitivity of clinical trial data, careful attention to data security and access control configuration is essential, ensuring the model only accesses authorized information.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
Chunk size (Chunk Size) | 500–800 characters | Clinical protocols and inclusion/exclusion criteria often have long paragraphs. This avoids truncation of critical information while ensuring recall efficiency. |
Chunk Overlap Length (Overlap Size) | 50 characters | Ensures contextual continuity and prevents critical information boundaries from becoming blurred due to segmentation. |
Recall count (Recall Count) | Top 5 | Clinical trial pre-screening decisions rely on a small number of highly relevant key clauses, reducing interference from irrelevant information. |
Similarity threshold (Similarity Threshold) | 0.75–0.85 | Ensures high relevance of recall results, excluding semantically similar but not precisely matching interference. |
Rerank result count (Rerank Count) | Top 3 | Further refines recall results, improving model processing efficiency and answer accuracy. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Parsing large clinical trial protocol PDF files can take a long time. |
Three Common Mistakes
- The model fails to reference the latest inclusion/exclusion criteria from the knowledge base when answering pre-screening questions, leading to outdated or incorrect judgments. This is due to improper configuration of the knowledge base's synchronization update mechanism or untimely triggering of incremental indexing.
- The model cannot accurately interpret a subject's laboratory test results, such as distinguishing different unit representations or normal value ranges. This is due to a lack of targeted field standardization and unit conversion rules during data preprocessing.
- When calling external tools for drug interaction queries, the model's context is interrupted, preventing multi-turn conversations. This occurs when tool call configurations do not properly handle context transfer, leading to model state loss.
How to Verify Configuration
- Upload a clinical trial protocol document containing the latest subject inclusion/exclusion criteria. Verify that the knowledge base can correctly parse and index its key clauses.
- Input a pre-screening question that includes specific laboratory test results (e.g., hemoglobin
120 g/L). Observe whether the model can accurately identify units and make judgments based on the normal value ranges in the knowledge base. - Simulate a complete pre-screening process, including multi-turn conversations and calling external tools to query drug information. Confirm that the model maintains contextual coherence throughout the process and provides logically correct recommendations.
The values provided are common starting points and should be measured against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.